9 Ways Menopause Has a Financial Impact Women Don't Expect
The thing that stings most about this topic is how invisible it stays. Women absorb these costs — in sick days, reduced hours, passed-over promotions — and assume it's just their own failing. It's not. The financial hit is structural, and naming it out loud is the beginning of doing something about it.
Learn more about Rose →Lost Workdays From Unmanaged Symptoms
A 2023 Mayo Clinic study estimated that menopause symptoms cost US women approximately $1.8 billion in lost working time annually, driven primarily by hot flashes, sleep disruption, and mood changes. Women experiencing moderate to severe symptoms miss significantly more days than symptomatic peers who receive treatment. Because menopause is rarely listed on sick-leave forms, this absenteeism is almost never captured or supported at the organisational level.
Reduced Productivity While Still Showing Up
Presenteeism — being physically present but cognitively or physically impaired — may be even more costly than absenteeism. Brain fog, fatigue, and poor sleep quality all compromise concentration, decision speed, and accuracy in ways that are hard to quantify but very real on a performance review. One UK survey found that 59% of working women said menopause symptoms negatively affected their ability to do their job well.
Career Deceleration at Peak Earning Years
Perimenopause typically arrives between ages 45 and 55 — exactly when many women are positioned for their highest-earning decade. Symptoms that reduce performance, confidence, or availability during this window can result in missed promotions, passed-over leadership roles, or stepping back from high-visibility projects. Research from the British Menopause Society found that 1 in 10 women left their job entirely due to menopause symptoms, permanently capping their career trajectory.
The Cost of Delayed or Misdiagnosed Treatment
Women in menopause are frequently misdiagnosed — with depression, anxiety, thyroid disorders, or chronic fatigue — before the hormonal root cause is identified. Each misdiagnosis can mean months or years of incorrect treatment, unnecessary specialist referrals, and medications that don't work, all of which carry direct out-of-pocket costs. A 2022 NICE review noted that women often see three or more healthcare providers before receiving an accurate menopause diagnosis.
Out-of-Pocket Healthcare Spending That Adds Up Fast
Even in countries with public healthcare, menopause-related costs accumulate: GP and specialist visits, hormone testing, private gynaecology or menopause clinic appointments, and prescription costs for HRT or non-hormonal treatments. In the US, women without menopause coverage through employer health plans can face thousands of dollars annually in uncovered costs. Sleep aids, joint supplements, and pelvic floor physiotherapy — all commonly needed — are rarely fully covered.
Sleep Disruption and Its Downstream Economic Costs
Chronic sleep deprivation — a hallmark of perimenopause — is independently associated with reduced cognitive performance, increased accident risk, and lower workplace output. Research from the RAND Corporation found that sleep-deprived workers cost the US economy over $400 billion annually in lost productivity, and women in midlife are disproportionately represented among chronic poor sleepers. The economic drag of night sweats and insomnia is rarely traced back to hormones, even when that's precisely the cause.
Pension and Retirement Savings Gaps Caused by Career Interruptions
Women who reduce hours, take unpaid leave, or exit the workforce due to menopause symptoms during their late forties and fifties directly reduce superannuation or pension contributions during the years that compound most significantly. Even a two-year career interruption at 50 can translate into a materially smaller retirement fund by 65, particularly when employer matching contributions are also lost. This compounds the pre-existing gender pension gap, which already leaves women with significantly less retirement income than men on average.
Mental Health Treatment Costs Masking a Hormonal Problem
Anxiety, low mood, and irritability in perimenopause are physiologically driven by fluctuating oestrogen, yet they are frequently treated as primary psychiatric conditions. Women may spend years paying for antidepressants, therapy, or psychiatric consultations that address symptoms but not the underlying hormonal cause — costs that could be partially or fully avoided with correct diagnosis. This is not an argument against mental health care, but a recognition that misdirected treatment is expensive and delays genuine relief.
The Long-Term Cost of Untreated Bone and Heart Health
Oestrogen plays a protective role in both cardiovascular health and bone density, and its decline after menopause is directly linked to increased risk of osteoporosis and heart disease — two of the most expensive chronic conditions women face in later life. Hip fracture alone, which risk rises sharply post-menopause, carries average treatment costs of $30,000–$50,000 in the US and significant long-term care implications. Investing in bone density scans, appropriate treatment, and preventive lifestyle measures during the menopause transition is genuinely cost-effective over a lifetime horizon.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.